Newsroom | 5508 results
Sorted by: Latest
-
Fariba Goodarzian, MD, Named Radiologist-in-Chief at Children's Hospital Los Angeles
LOS ANGELES--(BUSINESS WIRE)--Children’s Hospital Los Angeles has named Fariba Goodarzian, MD, Radiologist-in-Chief and Chair of Radiology and Imaging....
-
IPS HEART Secures 8th FDA Regulatory Milestone with Rare Pediatric Drug Designation for Cardiomyopathy Associated with Muscular Dystrophies
HOUSTON--(BUSINESS WIRE)--IPS HEART, Inc., a biopharmaceutical company pioneering induced pluripotent stem cell (iPSC)-derived cell replacement therapies, announced that the FDA has granted Rare Pediatric Drug Designation for ISX9-CPC, for the treatment of cardiomyopathies associated with dystrophinopathies. Redefining the Therapeutic Paradigm: Generating New Human Muscle Duchenne muscular dystrophy (DMD) leads to progressive skeletal muscle loss, severe cardiac fibrosis, and premature death fr...
-
Teleflex Announces Quarterly Dividend
WAYNE, Pa.--(BUSINESS WIRE)--Teleflex Incorporated (NYSE: TFX) announced today that its Board of Directors declared a quarterly cash dividend of thirty-four cents ($0.34) per share of common stock. The dividend is payable September 30, 2026, to shareholders of record at the close of business on August 14, 2026. About Teleflex Incorporated As a global provider of medical technologies, Teleflex is driven by our purpose to improve the health and quality of people’s lives. Through our vision to bec...
-
Teleflex Reports Second Quarter Financial Results and Full Year 2026 Outlook
WAYNE, Pa.--(BUSINESS WIRE)--Teleflex Incorporated (NYSE: TFX) (the “Company”) today announced financial results for the second quarter ended June 30, 2026. Second quarter 2026 continuing operations financial summary1 Revenue from continuing operations of $570.3 million, up 28.9% compared to the prior year period, and up 4.7% on a pro forma adjusted constant currency basis1,2 GAAP diluted EPS from continuing operations of $0.96, compared to $1.54 in the prior year period Adjusted diluted EPS fr...
-
QT Imaging to Report Second Quarter 2026 Financial Results and Host Conference Call on August 12, 2026
NOVATO, Calif.--(BUSINESS WIRE)--QT Imaging Holdings, Inc. (Nasdaq: QTI) (“QT Imaging” or the “Company”), a medical device company dedicated to transforming breast health management through innovative, radiation-free imaging technology, today announced that it will report financial results for the second quarter ended June 30, 2026, after market close on Wednesday, August 12, 2026, and will host a conference call beginning at 4:30 p.m. Eastern Time. Participants are encouraged to pre-register a...
-
ZAP Surgical Expands Presence in China with Eighth ZAP-X Installation
SAN CARLOS, Calif.--(BUSINESS WIRE)--ZAP Surgical Systems, Inc., a global leader in non-invasive robotic brain surgery, today announced that Changchun Tumor Hospital in Jilin Province is the latest institution in China to offer the ZAP-X® Gyroscopic Radiosurgery® platform, increasing the company's footprint in China to eight systems. With this installation, Changchun Tumor Hospital joins an elite group of neuro-oncology programs worldwide providing patients with state-of-the-art stereotactic ra...
-
Archeus Technologies Reconstitutes Advisory Board to Advance Clinical-Stage Radiopharmaceutical Pipeline
MADISON, Wis.--(BUSINESS WIRE)--Archeus Technologies, a clinical-stage company advancing a portfolio of differentiated small-molecule radiopharmaceutical therapies (RPTs) to address some of the most difficult-to-treat cancers, today announced the reconstitution of its Advisory Board, appointing five leaders with deep expertise across clinical development, drug discovery, and biopharmaceutical leadership. “The Advisory Board has been rebuilt to reflect where Archeus is today — a company with two...
-
GE HealthCare expands the LOGIQ e ultrasound platform with new LOGIQ e family
CHICAGO--(BUSINESS WIRE)--GE HealthCare today announced the introduction of the LOGIQ™ e family, featuring LOGIQ™ e Xi and LOGIQ™ e Si, two compact laptop ultrasound systems designed to help clinicians deliver simple, fast, and confident ultrasound imaging where it’s needed across care settings.ii Building on the legacy of LOGIQ e, the LOGIQ e family pairs a reliable console-level performance with a compact, intuitive design combining AI-powered featuresiii and workflow tools that support porta...
-
QT Imaging Advances Direct U.S. Commercial Strategy to Accelerate Adoption of its Breast Acoustic CT Scanner with Two Key Hires
NOVATO, Calif.--(BUSINESS WIRE)--QT Imaging Holdings, Inc. (Nasdaq: QTI) (“QT Imaging” or the “Company”), a medical device company dedicated to transforming breast health management through innovative, radiation-free imaging technology, today advanced the direct U.S. commercial strategy for its Breast Acoustic CT™ Scanner with the appointment of Jason Dyer as Vice President Regional Sales East and Dave Reinhart as Vice President Regional Sales West. Both executives joined QT Imaging in July 202...
-
Cottage Health and Thesis Announce Innovation Partnership to Expand Clinical Capacity and Support World-Class Patient Care
NEW YORK & SANTA BARBARA, Calif.--(BUSINESS WIRE)--Thesis Care, the AI-powered care team platform for scalable clinical capacity, and Cottage Health, the leading not-for-profit health system serving California's Central Coast, today announced a strategic innovation partnership. Through the collaboration, which marks the first health system partnership for Thesis, Cottage Health will deploy Thesis's AI care team agents to support high-impact clinical operations and care management workflows. Cot...